Jounce Therapeutics, Inc.
JNCE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $151 | $96 | $147 | $53 |
| Short-Term Investments | $39 | $83 | $59 | $116 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $12 | $5 | $5 |
| Total Curr. Assets | $197 | $191 | $211 | $174 |
| Property Plant & Equip (Net) | $12 | $17 | $22 | $28 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $42 | $7 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $4 | $2 |
| Total NC Assets | $15 | $62 | $33 | $32 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $213 | $253 | $244 | $206 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $2 |
| Short-Term Debt | $4 | $4 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $13 | $2 | $9 |
| Other Curr. Liab. | $17 | $0 | $12 | $0 |
| Total Curr. Liab. | $24 | $19 | $19 | $14 |
| LT Debt | $6 | $10 | $14 | $17 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $10 | $14 | $17 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $29 | $29 | $33 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$293 | -$242 | -$151 | -$107 |
| AOCI | -$1 | -$0 | -$0 | $0 |
| Other Equity | $477 | $466 | $362 | $282 |
| Total Equity | $183 | $224 | $211 | $175 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $213 | $253 | $244 | $206 |
| Net Debt | -$141 | -$82 | -$131 | -$33 |